Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MaxCyte Inc shares valued at $3,850 were sold by Soleymannezhad Ali on Mar 18 ’25. At $3.18 per share, Soleymannezhad Ali sold 1,211 shares. The insider’s holdings dropped to 59,439 shares worth approximately $0.13 million following the completion of this transaction.
Also, Sandoval David I. sold 353 shares, netting a total of over 1,122 in proceeds. Following the sale of shares at $3.18 each, the insider now holds 64,219 shares.
Before that, Swirsky Douglas J had sold 6,939 shares from its account. In a trade valued at $22,061, the CHIEF FINANCIAL OFFICER traded MaxCyte Inc shares for $3.18 each. Upon closing the transaction, the insider’s holdings decreased to 6,939 shares, worth approximately $0.24 million.
As published in their initiating research note from Craig Hallum on November 29, 2023, MaxCyte Inc [MXCT] has been a Buy and the price target has been revised to $7. As of August 24, 2021, William Blair has initiated its “an Outperform” rating for MXCT. Earlier on August 24, 2021, Wedbush initiated its rating. Their recommendation was “an Outperform” for MXCT stock.
Analyzing MXCT Stock Performance
On last trading session,, MaxCyte Inc [NASDAQ: MXCT] plunged -1.86% to $2.11. The stock’s lowest price that day was $2.1, but it reached a high of $2.18 in the same session. During the last five days, there has been a drop of approximately -8.26%. Over the course of the year, MaxCyte Inc shares have dropped approximately -49.28%. Shares of the company reached a 52-week high of $5.20 on 01/21/25 and a 52-week low of $2.10 on 06/18/25.
Support And Resistance Levels for MaxCyte Inc (MXCT)
According to the 24-hour chart, there is a support level at 2.08, which, if violated, would cause prices to drop to 2.05. In the upper region, resistance lies at 2.16. The next price resistance is at 2.21. RSI (Relative Strength Index) is 39.51 on the 14-day chart, showing neutral technical sentiment.
Is MaxCyte Inc subject to short interest?
Stocks of MaxCyte Inc saw a sharp rise in short interest on 2025-05-30 jumping by 2955.0 shares to 3.54 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 3.54 million shares. A jump of 0.08% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.89 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.89.
Which companies own the most shares of MaxCyte Inc (MXCT)?
In terms of MaxCyte Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 179.07% from the previous closing price of $2.15. Analysts anticipate MaxCyte Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 2 analysts ranked MaxCyte Inc stock as Buy at the end of 2025. On August 24, 2021, Stifel assigned a price target of “a Buy” to the stock and initiated coverage with a $18.
